Mission Bio Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 92

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 25

Mission Bio General Information

Description

Developer of a precision genomics platform designed to provide single-cell targeted DNA sequencing at single-base resolution. The company's platform integrates targeted sequencing with protein expression profiling at single-cell resolution, supports detection of single-nucleotide and copy number variations, enables characterization of clonal heterogeneity and gene edits, and includes customizable panels and assay development services, enabling researchers and clinicians in oncology and cell therapy to uncover genetic diversity, improve therapeutic targeting, and accelerate biomarker discovery.

Contact Information

Formerly Known As
Torrent Bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 Utah Avenue
  • Suite 210
  • San Francisco, CA 94080
  • United States
+1 (415)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 300 Utah Avenue
  • Suite 210
  • San Francisco, CA 94080
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mission Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Secondary Transaction - Private 01-Feb-2026 Completed Generating Revenue
14. Later Stage VC 04-Aug-2025 Completed Generating Revenue
13. Later Stage VC (Series D) 06-May-2022 Completed Generating Revenue
12. Debt - General 01-Jan-2022 Completed Generating Revenue
11. Later Stage VC (Series C) 13-Aug-2020 Completed Generating Revenue
10. Grant 12-Sep-2019 Completed Generating Revenue
9. Later Stage VC (Series B) 13-Jul-2018 Completed Generating Revenue
8. Later Stage VC (Series A) 09-Jun-2017 Completed Generating Revenue
7. Grant 14-Feb-2017 $100K Completed Startup
6. Accelerator/Incubator 01-Jan-2017 $100K $100K Completed Startup
To view Mission Bio’s complete valuation and funding history, request access »

Mission Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 24,442,312 $0.000010 8% $1.23 $1.23 $1.23 18.13%
Series A 26,192,697 $0.000010 8% $0.55 $0.55 $0.55 19.43%
To view Mission Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Mission Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a precision genomics platform designed to provide single-cell targeted DNA sequencing at single-base resolu
Discovery Tools (Healthcare)
San Francisco, CA
92 As of 2026

Cambridge, United Kingdom
 

Munich, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mission Bio Competitors (23)

One of Mission Bio’s 23 competitors is Sphere Fluidics, a Formerly VC-backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Formerly VC-backed Cambridge, United Kingdom
Nanion Technologies Accelerator/Incubator Backed Munich, Germany
Genewiz Formerly VC-backed South Plainfield, NJ
Standard BioTools Formerly VC-backed Boston, MA
1CellBio Corporation Cambridge, MA
You’re viewing 5 of 23 competitors. Get the full list »

Mission Bio Patents

Mission Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023196928-A2 True variant identification via multianalyte and multisample correlation Inactive 06-Apr-2022
WO-2023196928-A3 True variant identification via multianalyte and multisample correlation Inactive 06-Apr-2022
WO-2023154816-A1 Systems and methods of detecting merged droplets in single cell sequencing Inactive 09-Feb-2022
WO-2023141604-A2 Methods of molecular tagging for single-cell analysis Inactive 21-Jan-2022
WO-2023141604-A3 Methods of molecular tagging for single-cell analysis Inactive 21-Jan-2022 C12Q1/6806
To view Mission Bio’s complete patent history, request access »

Mission Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mission Bio Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Charles & Potomac Capital Family Office Minority
UCSF Innovation Ventures Venture Capital Minority
Ally Bridge Group Growth/Expansion Minority
Cambrian Growth Partners Growth/Expansion Minority
Dais Partners Growth/Expansion Minority
You’re viewing 5 of 25 investors. Get the full list »

Mission Bio FAQs

  • When was Mission Bio founded?

    Mission Bio was founded in 2011.

  • Where is Mission Bio headquartered?

    Mission Bio is headquartered in San Francisco, CA.

  • What is the size of Mission Bio?

    Mission Bio has 92 total employees.

  • What industry is Mission Bio in?

    Mission Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Mission Bio a private or public company?

    Mission Bio is a Private company.

  • What is Mission Bio’s current revenue?

    The current revenue for Mission Bio is .

  • How much funding has Mission Bio raised over time?

    Mission Bio has raised $212M.

  • Who are Mission Bio’s investors?

    Charles & Potomac Capital, UCSF Innovation Ventures, Ally Bridge Group, Cambrian Growth Partners, and Dais Partners are 5 of 25 investors who have invested in Mission Bio.

  • Who are Mission Bio’s competitors?

    Sphere Fluidics, Nanion Technologies, Genewiz, Standard BioTools, and 1CellBio are some of the 23 competitors of Mission Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process